TrialSchizophrenia bulletin2023

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.

Christoph U Correll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.